Christopher Francis Rowley

Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.

Canaday DH, Carias L, Oyebanji OA, Keresztesy D, Wilk D, Payne M, Aung H, Denis KS, Lam EC, Wilson B, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Balazs AB, Gravenstein S, King CL.

medRxiv. 2021 Mar 22. PMID: 33791727

High Inpatient Health Care Utilization and Charges Associated With Injection Drug Use-Related Infections: A Cohort Study, 2012-2015.

Rapoport AB, Fine DR, Manne-Goehler JM, Herzig SJ, Rowley CF.

Open Forum Infect Dis. 2021 Mar. 8(3):ofab009. PMID: 33728355

PANDAA intentionally violates conventional qPCR design to enable durable, mismatch-agnostic detection of highly polymorphic pathogens.

MacLeod IJ, Rowley CF, Essex M.

Commun Biol. 2021 Feb 18. 4(1):227. PMID: 33603155

Surgical cure of clarithromycin resistant Mycobacterium chelonae breast implant infection: A case report and review of the literature.

Jhaveri VV, Singhal D, Riedel S, Rowley CF, Nathavitharana RR.

J Clin Tuberc Other Mycobact Dis. 2020 Dec. 21:100183. PMID: 32964146

Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy.

Ajibola G, Rowley C, Maruapula D, Leidner J, Bennett K, Powis K, Shapiro RL, Lockman S.

South Afr J HIV Med. 2020. 21(1):1023. PMID: 32158555

Opioid use disorder and infectious complications in persons who inject drugs.

Li A, Rosenthal ES, Rapoport AB, Rowley CF.

Int Anesthesiol Clin. 2020. 58(2):4-11. PMID: 32073421

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.

Seatla KK, Choga WT, Mogwele M, Diphoko T, Maruapula D, Mupfumi L, Musonda RM, Rowley CF, Avalos A, Kasvosve I, Moyo S, Gaseitsiwe S.

PLoS One. 2019. 14(11):e0224292. PMID: 31751353

High Morbidity and Mortality Among Patients With Sentinel Admission for Injection Drug Use-Related Infective Endocarditis.

Leahey PA, LaSalvia MT, Rosenthal ES, Karchmer AW, Rowley CF.

Open Forum Infect Dis. 2019 Apr. 6(4):ofz089. PMID: 30949535

Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana.

Seatla KK, Avalos A, Moyo S, Mine M, Diphoko T, Mosepele M, Gaolatlhe T, Rowley CF, Ramaabya D, Jarvis JN, Kasvosve I, Gaseitsiwe S.

AIDS. 2018 08 24. 32(13):1899-1902. PMID: 29894383

Infectious Diseases Physicians' Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017.

Rapoport AB, Fischer LS, Santibanez S, Beekmann SE, Polgreen PM, Rowley CF.

Open Forum Infect Dis. 2018 Jul. 5(7):ofy132. PMID: 30018999